$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Parenteral bisphosphonate composition with improved local tolerance 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/66
출원번호 US-0758605 (2001-01-11)
우선권정보 EP-0101044 (2000-01-20)
발명자 / 주소
  • Diederich, Anke
  • Goldbach, Pierre
  • Pfister, Thomas
출원인 / 주소
  • Hoffmann-La Roches Inc.
대리인 / 주소
    Johnston, George W.Rocha-Tramaloni, Patricia S.Lau, Bernard
인용정보 피인용 횟수 : 31  인용 특허 : 25

초록

The present invention relates to a parenteral composition comprising a bisphosphonic acid or a pharmaceutically acceptable salt thereof (bisphosphonate) as active component and a pharmaceutically acceptable chelating agent, processes of the preparation of this composition, and methods of their use i

대표청구항

1. A method for the treatment and prevention of diseases involving bone resorption, osteoporosis, Paget's disease, hypercalcemia of malignancy, and metabolic bone disease comprising the step of administering to a patient in need of such treatment and prevention a parenteral composition having a pH o

이 특허에 인용된 특허 (25)

  1. Isomura Yasuo (Tokyo JPX) Takeuchi Makoto (Tokyo JPX) Sakamoto Shuichi (Tokyo JPX) Abe Tetsushi (Saitama JPX), (Cycloalkylamino)methylenebis(phosphonic acid).
  2. Blum Helmut (Dusseldorf DT) Worms Karl-Heinz (Dusseldorf DT), 1-Hydroxy-3-amino-alkane-1,1-diphosphonic acids and salts.
  3. Gall Rudi (Mannheim DEX) Bosies Elmar (Mannheim DEX), 1-hydroxy-3-(N-methyl-N-propylamino)propane-1,1-diphosphonic acid, pharmaceutical compositions and methods of use.
  4. Blum Helmut (Duesseldorf DEX) Hemmann Siglinde (Meerbusch DEX), 4-dimethylamino-1-hydroxybutane-1,1-diphosphonic acid, salts thereof, and processes therefor.
  5. Breliere Jean C. (Montpellier FRX) Emonds-Alt Xavier (Montpellier FRX) Garcia Georges (Saint-Gely-du-Fesc FRX), Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation.
  6. Breliere Jean C. (Montpellier FRX) Emonds-Alt Xvier (Montpellier FRX) Garcia Georges (Saint-Gely-du-Fesc FRX), Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation.
  7. Daifotis Anastasia G. (Westfield NJ) Yates Ashley J. (Westfield NJ), Bisphosphonates prevent bone loss associated with immunosuppressive therapy.
  8. Blackwell ; III Joseph T. (Greensboro NC) Grace Henry C. (Baton Rouge LA) Nabors James B. (Baton Rouge LA) Petree Harris E. (Kernersville NC), Chemical process for the preparation of 2,6-dialkylcyclohexylamines from 2,6-dialkylphenols.
  9. Gall Rudi (Hirschberg DEX) Bosies Elmar (Weinheim DEX), Diphosphonate derivatives, pharmaceutical compositions and methods of use.
  10. Bosies Elmar (Weinheim DEX) Gall Rudi (Hirschberg DEX), Diphosphonate derivatives, pharmaceutical compositions and methods of use for calcium disturbances.
  11. Bosies Elmar (Weinheim DEX) Zilch Harald (Mannheim DEX), Diphosphonic acid compounds and use for calcium metabolism disorders.
  12. Bosies Elmar (Weinheim DEX) Gall Rudi (Hirschberg DEX), Diphosphonic acid derivatives.
  13. Bosies Elmar (Weinheim DEX) Gall Rudi (Hirschberg DEX), Diphosphonic acid derivatives, pharmaceutical compositions and methods.
  14. Bosies Elmar (Weinheim DEX) Gall Rudi (Hirschberg DEX), Diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.
  15. Blum Helmut (Dsseldorf DEX) Hempel Hans-Ulrich (Overath DEX) Worms Karl-Heinz (Dsseldorf DEX), Hydroxyalkane diphosphonic acids.
  16. Sage ; Jr. Burton H. ; Green Philip G., Method for the iontophoretic administration of bisphosphonates.
  17. Gordon Larry E. (Chelmsford MA), Method of laser marking metal packages.
  18. Schmidt-Dunker Manfred (Dusseldorf DT), Method of treatment of calcium disorders using aminoalkane-diophosphonic acids.
  19. Rosini Sergio (Pisa ITX) Staibano Giorgio (Pisa ITX), Pharmacologically active biphosphonates, process for the preparation thereof and pharmaceutical compositions therefrom.
  20. Cirelli Giorgio (Nussbaumen CHX) Steffen Hans (Liestal CA CHX) Surber Christian (San Francisco CA), Portable injection appliance.
  21. Kieczykowski Gerard R. (Westfield NJ), Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof.
  22. Blum Helmut (Dusseldorf DEX) Worms Karl-Heinz (Dusseldorf DEX), Process for the production of 3-amino-1-hydroxypropane-1,1-diphosphonic acid.
  23. Blum Helmut (Dusseldorf DEX) Worms Karl-Heinz (Dusseldorf DEX), Process for the production of w 상세보기
  • Flora Lawrence (Fairfield OH) Floyd Benjamin F. (Cincinnati OH), Regimen for treating osteoporosis.
  • Bosies Elmar (Weinheim DEX) Gall Rudi (Hirschberg DEX), Triazole containing diphosphonate compounds and the use thereof.
  • 이 특허를 인용한 특허 (31)

    1. Hanna, Mazen; Shan, Ning; Cheney, Miranda L.; Weyna, David R.; Isbester, Paul K.; Sun, Xufeng, Crystalline forms.
    2. Hanna, Mazen, Crystallization method and bioavailability.
    3. Hanna, Mazen; Shan, Ning; Cheney, Miranda L.; Weyna, David R.; Houck, Raymond, Crystallization method and bioavailability.
    4. Hanna, Mazen; Shan, Ning; Cheney, Miranda L.; Weyna, David R.; Houck, Raymond, Crystallization method and bioavailability.
    5. Hanna, Mazen; Shan, Ning; Cheney, Miranda L.; Weyna, David R.; Houck, Raymond K., Crystallization method and bioavailability.
    6. Hanna, Mazen; Shan, Ning; Cheney, Miranda L.; Weyna, David R.; Houck, Raymond K., Crystallization method and bioavailability.
    7. Hanna, Mazen; Shan, Ning; Cheney, Miranda; Weyna, David; Houck, Raymond K., Crystallization method and bioavailability.
    8. Dansereau, Richard John; Burgio, Jr., David Ernest, Dosage forms of bisphosphonates.
    9. Dansereau, Richard John; Burgio, Jr., David Ernest, Dosage forms of bisphosphonates.
    10. Dansereau, Richard John; Burgio, Jr., David Ernest, Dosage forms of bisphosphonates.
    11. Dansereau, Richard John; Burgio, Jr., David Ernest, Dosage forms of risedronate.
    12. DiPerna, Paul M, Flow regulating stopcocks and related methods.
    13. McManus, Samuel P.; Kozlowski, Antoni, Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom.
    14. McManus, Samuel P.; Kozlowski, Antoni, Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom.
    15. Bobyn, John Dennis; Tanzer, Michael, Implant improving local bone formation.
    16. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
    17. DiPerna, Paul M.; Brown, David; Rosinko, Mike; Kincade, Dan; Michaud, Michael; Nadworny, John; Kruse, Geoffrey A.; Ulrich, Thomas R., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
    18. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
    19. Michaud, Michael; Kruse, Geoffrey A., Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
    20. Verhoef, Erik T.; DiPerna, Paul M.; Rosinko, Mike; Williamson, Mark; Kruse, Geoffrey A.; Ulrich, Thomas R.; Lamb, Phil; Saint, Sean; Michaud, Michael; Trevaskis, William, Infusion pump system with disposable cartridge having pressure venting and pressure feedback.
    21. Zhang, Jack Yongfeng; Luo, Mary Ziping; Fei, Dingyuan; Xie, Kevin; Ding, Jie Fei, Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate.
    22. Dansereau, Richard John; Burgio, Jr., David Ernest, Low dosage forms of risedronate or its salts.
    23. Dansereau, Richard John; Burgio, Jr., David Ernest, Low dosage forms of risedronate or its salts.
    24. Liu, Gang; Men, Ping, Methods for chelation therapy.
    25. Liversidge, Gary G.; Jenkins, Scott, Nanoparticulate bisphosphonate compositions.
    26. DiPerna, Paul M., Slideable flow metering devices and related methods.
    27. Brown, David, Solute concentration measurement device and related methods.
    28. Rosinko, Michael J.; Kruse, Geoffrey A.; Harris, Paul, System and method for detecting occlusions in an infusion pump.
    29. Metzmaker, Thomas; Saint, Sean; Michaud, Michael; Rosinko, Michael J.; Swanson, Vance, Systems including vial adapter for fluid transfer.
    30. DiPerna, Paul M., Two chamber pumps and related methods.
    31. von Andrian, Ulrich H.; Iannacone, Matteo; Tonti, Elena; Moseman, Elliott Ashley, Vaccines comprising bisphosphonate and methods of use thereof.
    섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로